Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01340001
Other study ID # 2011/049/HP
Secondary ID 2011-A00387-34
Status Completed
Phase N/A
First received
Last updated
Start date October 24, 2012
Est. completion date December 22, 2017

Study information

Verified date April 2018
Source University Hospital, Rouen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Deep brain stimulation has been developed as a substitute for the classical lesioning methods previously used in stereotactic and functional neurosurgery. Recent, anecdotal cases reports suggested that electrical stimulation of the cholinergic output of the Nucleus Basalis of Meynert (NBM) may improve cognitive performances, especially the memory tasks.

The present study aims to assess the effect of bilateral electrical stimulation of the NBM on the mnesic performance [assessed by the sum of the three free recalls of the Free and Cued Selective Recall Reminding Test (FCSRT)] in patients diagnosed with probable, moderate, Dementia with Lewy Bodies.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date December 22, 2017
Est. primary completion date December 22, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Diagnosis of probable Lewy-body dementia according to the internationally accepted consensus criteria (McKeith, 2005)

- Outpatients, male or female, aged between 18 to 75 years

- Moderate dementia defined by a mini-mental state examination (MMSE) score between 16 and 26

- Stable dose of cholinesterase inhibitors (maximal dose tolerated) for a minimum of 1 months

- Patients receiving antiparkinsonian treatment unmodified for 3 months, if treated

- French as native language

- Written informed consent of the patient

- Written informed consent of the caregiver

Exclusion Criteria:

- Other causes of dementia (Alzheimer dementia, vascular dementia, dementia associated with Parkinson's disease)

- Other causes of extrapyramidal symptoms (Parkinson's disease)

- Patients with a history of severe psychiatric disorders, such as psychosis. Earlier episodes of depression and/or anxiety without hospitalization are not exclusion criteria

- Contraindications for MR imaging (claustrophobia, metallic foreign bodies, pacemakers, etc)

- MRI evidence of cerebral microbleeds

- Surgical contraindications: especially, hemostatic disorders, severe cortical atrophy

- Patients receiving treatments that may interfere with the cholinergic system: anticholinergics, cholinomimetics.

- Patients receiving neuroleptics

- Patients with a history of alcohol or drug abuse

- Pre-existing structural brain abnormalities (such as tumor, infarction, or intracranial hematoma)

- Previous neurosurgical intervention

- Patients with a progressively fatal disease, or life expectancy £ one year

- Asthma

- Severe visual deficit of ophthalmic origin (such as glaucoma, age related macular degeneration, cataract)

- Fertile women not using adequate contraceptive methods

- Women who are pregnant or breast feeding

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Electrical stimulation of the nucleus basalis of Meynert
Differents parameters will be assessed.

Locations

Country Name City State
France Maltête David Rouen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary free recalls of the FCSRT The primary endpoint of the study is the difference in the sum of the three free recalls of the FCSRT between the assessments (M7) and (M10), i.e. the comparison of the performances with and without NBM electrical stimulation. between the assessments (Month 7) and (Month 10)
Secondary performances on different tests Comparison will be made between the performances on different tests recorded at M7 and M10, to evaluate the effect of bilateral electrical stimulation of the NBM on cognitivo-behavioral disorders. different tests recorded at Month 7 and Month 10
See also
  Status Clinical Trial Phase
Recruiting NCT03996460 - K0706 for Patients Diagnosed With Dementia With Lewy Bodies Phase 2
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Recruiting NCT02194816 - Modifiable Variables in Parkinsonism (MVP)
Active, not recruiting NCT01208675 - The Swedish BioFINDER Study
Completed NCT03538522 - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 Phase 2
Recruiting NCT03672448 - The China Longitudinal Aging Study of Cognitive Impairment
Not yet recruiting NCT04760860 - Terazosin for Dementia With Lewy Bodies Phase 1/Phase 2
Completed NCT02910102 - Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia Phase 2
Terminated NCT02928445 - Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension Phase 2/Phase 3
Terminated NCT02871427 - Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder Phase 2
Completed NCT05188105 - Alpha tACS in Dementia With Lewy Bodies N/A
Active, not recruiting NCT04167813 - Trial of Ondansetron as a Parkinson's HAllucinations Treatment Phase 2
Enrolling by invitation NCT04954183 - Development of an EEG Diagnostic for Alzheimer's Disease
Recruiting NCT05326750 - Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases N/A
Completed NCT01023672 - "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies" Phase 4
Completed NCT03907748 - Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia N/A
Completed NCT04649164 - Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia N/A
Recruiting NCT03924414 - Trial of Parkinson's And Zoledronic Acid Phase 4
Completed NCT05885620 - SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and Dementia N/A
Not yet recruiting NCT04555629 - Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK) N/A